Delek US (NYSE:DK – Get Free Report) had its price objective hoisted by equities research analysts at The Goldman Sachs Group from $73.00 to $83.00 in a research report issued on Tuesday, Marketbeat Ratings reports. The brokerage currently has a “buy” rating on the oil and gas company’s stock. The Goldman Sachs Group’s target price points to a potential upside of 23.62% from the stock’s previous close.
A number of other research firms have also recently weighed in on DK. Citigroup reiterated a “neutral” rating on shares of Delek US in a research report on Thursday, August 6th. TD Cowen lifted their price target on shares of Delek US from $58.00 to $76.00 and gave the stock a “buy” rating in a research note on Tuesday, July 21st. Raymond James Financial lifted their price target on shares of Delek US from $60.00 to $70.00 and gave the stock an “outperform” rating in a research note on Monday, July 13th. JPMorgan Chase & Co. increased their price objective on shares of Delek US from $57.00 to $62.00 and gave the stock a “neutral” rating in a research report on Tuesday, July 14th. Finally, Zacks Research raised shares of Delek US from a “hold” rating to a “strong-buy” rating in a research note on Friday, June 26th. One investment analyst has rated the stock with a Strong Buy rating, six have given a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus price target of $53.15.
Read Our Latest Analysis on DK
Delek US Price Performance
Delek US (NYSE:DK – Get Free Report) last released its quarterly earnings results on Wednesday, August 5th. The oil and gas company reported $5.48 earnings per share for the quarter, beating the consensus estimate of $2.67 by $2.81. The company had revenue of $4.09 billion for the quarter, compared to analyst estimates of $3.44 billion. Delek US had a return on equity of 109.03% and a net margin of 1.86%.Delek US’s quarterly revenue was up 47.9% compared to the same quarter last year. During the same quarter in the prior year, the firm posted ($0.56) EPS. Equities analysts expect that Delek US will post 10.1 EPS for the current year.
Insider Transactions at Delek US
In other news, Director Vicky Sutil sold 1,871 shares of the firm’s stock in a transaction that occurred on Wednesday, June 3rd. The shares were sold at an average price of $48.00, for a total transaction of $89,808.00. Following the transaction, the director directly owned 29,368 shares of the company’s stock, valued at approximately $1,409,664. This trade represents a 5.99% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director William J. Finnerty sold 5,000 shares of Delek US stock in a transaction that occurred on Monday, June 29th. The shares were sold at an average price of $51.50, for a total transaction of $257,500.00. Following the sale, the director directly owned 34,805 shares of the company’s stock, valued at $1,792,457.50. This represents a 12.56% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 13,629 shares of company stock valued at $652,685 in the last quarter. 3.56% of the stock is currently owned by company insiders.
Institutional Inflows and Outflows
Several hedge funds and other institutional investors have recently bought and sold shares of DK. BlackRock Inc. purchased a new position in Delek US during the 2nd quarter worth $275,233,000. ION Fund Management Ltd purchased a new stake in shares of Delek US in the 4th quarter worth $52,427,000. Norges Bank bought a new position in shares of Delek US during the 4th quarter worth $48,374,000. Arrowstreet Capital Limited Partnership grew its position in shares of Delek US by 6,300.8% during the 3rd quarter. Arrowstreet Capital Limited Partnership now owns 1,306,269 shares of the oil and gas company’s stock worth $42,153,000 after buying an additional 1,285,861 shares in the last quarter. Finally, Price T Rowe Associates Inc. MD increased its stake in shares of Delek US by 1,516.7% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 996,059 shares of the oil and gas company’s stock valued at $29,544,000 after buying an additional 934,448 shares during the period. Institutional investors own 97.01% of the company’s stock.
About Delek US
Delek US Holdings, Inc (NYSE: DK) is an independent downstream energy company engaged in the refining, logistics, and marketing of petroleum products. Headquartered in Brentwood, Tennessee, the company operates a network of inland refineries, storage terminals and pipelines, and convenience store locations. Delek US focuses on converting crude oil into a variety of finished products, including gasoline, diesel, jet fuel, asphalt and renewable fuels, serving wholesale and retail customers across the United States.
In its refining segment, Delek US owns and operates four inland refineries located in Texas and Arkansas.
Further Reading
- Five stocks we like better than Delek US
- 3 Infrastructure Stocks Built Around the Backbone of the Economy
- Moonshot to Money: Intuitive Machines Lands $600M Defense Win
- Commodities Are Booming, But These 3 ETFs Tell Different Stories
- 3 Active ETFs Making Big Moves in August
Receive News & Ratings for Delek US Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Delek US and related companies with MarketBeat.com's FREE daily email newsletter.
